{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:09:08Z","timestamp":1785809348355,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Pamukkale University Scientific Resaerch Projects Unit","award":["2023TIPF006"],"award-info":[{"award-number":["2023TIPF006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10735-025-10485-5","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:10:18Z","timestamp":1751670618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of ntrk fusion in non-small cell lung cancers by immunohistochemical and molecular methods"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9979-3436","authenticated-orcid":false,"given":"Ubeydullah","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0243-2694","authenticated-orcid":false,"given":"Emel","family":"K\u0131l\u0131\u00e7arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-2753","authenticated-orcid":false,"given":"Burcu","family":"Yapar Ta\u015fk\u00f6yl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5538-7754","authenticated-orcid":false,"given":"Sevin","family":"Ba\u015fer \u00d6ncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-4383","authenticated-orcid":false,"given":"Ferda","family":"Bir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"issue":"6","key":"10485_CR1","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00408-020-00407-5","volume":"198","author":"M Alexander","year":"2020","unstructured":"Alexander M, Kim SY, Cheng H (2020) Update 2020: management of non-small cell lung cancer. Lung 198(6):897\u2013907. https:\/\/doi.org\/10.1007\/s00408-020-00407-5","journal-title":"Lung"},{"issue":"13","key":"10485_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s40265-019-01177-y","volume":"79","author":"ZT Al-Salama","year":"2019","unstructured":"Al-Salama ZT, Keam SJ (2019) Entrectinib: first global approval. Drugs 79(13):1477\u20131483. https:\/\/doi.org\/10.1007\/s40265-019-01177-y","journal-title":"Drugs"},{"issue":"2","key":"10485_CR3","doi-asserted-by":"publisher","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","volume":"1","author":"A Amatu","year":"2016","unstructured":"Amatu A, Sartore-Bianchi A, Siena S (2016) NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 1(2):e000023. https:\/\/doi.org\/10.1136\/esmoopen-2015-000023","journal-title":"ESMO Open"},{"issue":"2","key":"10485_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","volume":"34","author":"I Br\u010di\u0107","year":"2021","unstructured":"Br\u010di\u0107 I, Godschachner TM, Bergovec M et al (2021) Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions. Mod Pathol 34(2):396\u2013407. https:\/\/doi.org\/10.1038\/s41379-020-00657-x","journal-title":"Mod Pathol"},{"issue":"24","key":"10485_CR5","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.1093\/emboj\/17.24.7282","volume":"17","author":"ME Cunningham","year":"1998","unstructured":"Cunningham ME, Greene LA (1998) A function-structure model for NGF-activated TRK. EMBO J 17(24):7282\u20137293. https:\/\/doi.org\/10.1093\/emboj\/17.24.7282","journal-title":"EMBO J"},{"issue":"8","key":"10485_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S et al (2018) Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. New Engl J Med 378(8):731\u2013739. https:\/\/doi.org\/10.1056\/NEJMoa1714448","journal-title":"New Engl J Med"},{"issue":"8","key":"10485_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma N, Santana-Davila R, Molina JR (2019) Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc 94(8):1623\u20131640","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10485_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","volume":"41","author":"JF Hechtman","year":"2017","unstructured":"Hechtman JF, Benayed R, Hyman DM et al (2017) Pan-trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol 41(11):1547\u20131551. https:\/\/doi.org\/10.1097\/PAS.0000000000000911","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10485_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ng0298-184","volume":"18","author":"SR Knezevich","year":"1998","unstructured":"Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH (1998) A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18(2):184\u2013187. https:\/\/doi.org\/10.1038\/ng0298-184","journal-title":"Nat Genet"},{"issue":"19","key":"10485_CR10","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2014.3741","volume":"311","author":"MG Kris","year":"2014","unstructured":"Kris MG, Johnson BE, Berry LD et al (2014) Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 311(19):1998\u20132006. https:\/\/doi.org\/10.1001\/jama.2014.3741","journal-title":"JAMA"},{"key":"10485_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00183","author":"R Okamura","year":"2018","unstructured":"Okamura R, Boichard A, Kato S et al (2018) Analysis of NTRK alterations in pan-cancer adult and pediatric malignancies: implications for NTRK-targeted therapeutics. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.18.00183","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10485_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.semdp.2021.04.001","volume":"38","author":"E Paver","year":"2021","unstructured":"Paver E, O\u2019Toole S, Cheng XM, Mahar A, Cooper WA (2021) Updates in the molecular pathology of non-small cell lung cancer. Semin Diagn Pathol 38(5):54\u201361. https:\/\/doi.org\/10.1053\/j.semdp.2021.04.001","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10485_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40291-022-00617-y","volume":"27","author":"JD Silvertown","year":"2023","unstructured":"Silvertown JD, Lisle C, Semenuk L et al (2023) Prevalence of NTRK fusions in canadian solid tumour cancer patients. Mol Diagn Ther 27(1):87\u2013103. https:\/\/doi.org\/10.1007\/s40291-022-00617-y","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10485_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon JP, Linkov I, Rosado A et al (2020) NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33(1):38\u201346. https:\/\/doi.org\/10.1038\/s41379-019-0324-7","journal-title":"Mod Pathol"},{"issue":"1","key":"10485_CR15","doi-asserted-by":"publisher","first-page":"9785","DOI":"10.1038\/s41598-021-89373-3","volume":"11","author":"S Strohmeier","year":"2021","unstructured":"Strohmeier S, Brcic I, Popper H et al (2021) Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma. Sci Rep 11(1):9785. https:\/\/doi.org\/10.1038\/s41598-021-89373-3","journal-title":"Sci Rep"},{"issue":"6","key":"10485_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW (2022) Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol 40(6):611\u2013625. https:\/\/doi.org\/10.1200\/JCO.21.01626","journal-title":"J Clin Oncol"},{"issue":"4","key":"10485_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/cjp2.208","volume":"7","author":"R Zhao","year":"2021","unstructured":"Zhao R, Yao F, Xiang C et al (2021) Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population. J Pathol Clin Res 7(4):375\u2013384. https:\/\/doi.org\/10.1002\/cjp2.208","journal-title":"J Pathol Clin Res"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10485-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10485-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10485-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:00:54Z","timestamp":1757206854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10485-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10485"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10485-5","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"215"}}